Search for: "Tom Lamb"
Results 321 - 340
of 1,044
Sorted by Relevance
|
Sort by Date
6 Jun 2023, 7:50 am
(Attorney Tom Lamb does all case reviews) [read post]
19 Jul 2023, 10:30 am
(Attorney Tom Lamb does all case reviews) [read post]
15 Nov 2009, 3:37 am
Writes Tom Smith, addressing me: Perhaps Palin has chosen not to share all of her thinking and calculations with the reading public. [read post]
6 Feb 2008, 3:04 pm
Ezetimibe Component Of These Drugs Is Associated With Liver Failure, Acute Pancreatitis, Rhabdomyolysis, and Thrombocytopenia (Posted by Tom Lamb at DrugInjuryWatch.com) Ezetimibe is used alone (i.e., Zetia) or in combination with other antilipemic agents such as a statin or fenofibrate. [read post]
26 May 2009, 2:13 pm
While Levaquin Is Just One Of Several Antibiotics In Fluoroquinolone Class, All Of Which Have Been Linked To Tendon Ruptures, Levaquin Has Most Tendon Injury Lawsuits Filed To Date (Posted by Tom Lamb at DrugInjuryWatch.com) In late August 2006 the consumer advocacy group Public Citizen filed a petition with the FDA requesting that the agency order certain drug companies to put a "black-box" warning about the risks of… [read post]
11 Apr 2011, 12:04 pm
Public Citizen March 2011 Letter To FDA Points To Aclasta Safety Alert Material Sent In Canada During October 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) To start, Reclast is the U.S. name for the zoledronic acid medication sold by Novartis; it is identical to Aclasta, which Novartis sells in Canada. [read post]
22 Sep 2009, 1:30 pm
Serious Side Effects Include Heart Attacks, Abnormal Heart Rhythms, Heart Failure, And Various Conditions Caused By Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a July 16, 2009 MedWatch Email Alert we first learned about an ongoing FDA investigation of Xolair (omalizumab): FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) titled Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to… [read post]
14 May 2008, 11:54 am
Medtronic Had Initially Suggested That It Was Implant Technique That Caused The Sprint Fidelis Malfunctions (Posted by Tom Lamb at DrugInjuryWatch.com) For today's post we have to thank Westby G. [read post]
13 Apr 2007, 6:36 am
WSJ Reports That Judge Wilson's Ruling In This One Vioxx Case Could Affect Other 1000 Texas Vioxx Cases (Posted by Tom Lamb at DrugInjuryWatch.com) Reporter Heather Won Tesoriero broke the news in an April 13, 2007 Wall Street Journal (WSJ) article about Texas Vioxx cases:A ruling from a Texas judge coming as soon as Monday is expected to undercut the legal foundation for all 1,000 Vioxx cases brought against Merck & Co. by Texas plaintiffs, providing a potentially… [read post]
3 Dec 2008, 5:16 pm
Researchers Looked For Possible Digoxin-Related Adverse Drug Events In Older Patients From Pennsylvania (Posted by Tom Lamb at DrugInjuryWatch.com) In the wake of the generic digoxin pill Digitek being recalled in the spring of 2008, there has been an increased interest in determining the incidence of digoxin toxicity, also known as digitalis poisoning. [read post]
19 Sep 2012, 2:35 pm
These Fractures Have Several Atypical Characteristics: Prodromal Symptoms, Occurrence With Minimal Trauma, Distinctive Radiographic Changes (Posted by Tom Lamb at DrugInjuryWatch.com) Three new medical journal articles about bisphosphonate-related femur fractures came to our attention in early September 2012. [read post]
31 Jul 2008, 9:44 pm
(Posted by Tom Lamb at DrugInjuryWatch.com) A little more than two weeks ago I wrote a post entitled "FDA Needs To Assure Us That There Is Quality Control For Generic Medications Sold In U.S. [read post]
18 May 2009, 1:34 pm
A Comparison Of This "Fourth Generation" DRSP / EE Pill To Other Established Oral Contraceptives For Incidence Of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Heart Attack (MI), And Stroke (CVA) (Posted by Tom Lamb at DrugInjuryWatch.com) YAZ (3 mg drospirenone/20 mcg ethinyl estradiol) is an oral contraceptive (OC) which is the first pill to combine 20 mcg of ethinyl estradiol (EE) with the so-called "fourth generation"… [read post]
28 Dec 2007, 3:14 pm
Abnormal Liver Function Tests In Man With No Hepatotoxicity Risk Factors After Taking Ketek For Three Days Indicates Drug Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) As we have reported previously, use of the antibiotic Ketek appears to significantly increase one's risk of developing liver damage. [read post]
1 Oct 2008, 3:58 pm
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, And Erythema Multiforme Are Associated With Revlimid Use (Posted by Tom Lamb at DrugInjuryWatch.com) The Summer 2008 edition of the US FDA's Drug Safety Newsletter included an article concerning Revlimid (lenalidomide), a thalidomide analogue marketed by Celgene Corp. [read post]
9 Dec 2010, 2:43 pm
As Of December 2010 The Fourteen Jury Verdicts Are Evenly Split Between Defendant Pfizer And Plaintiffs (Posted by Tom Lamb at DrugInjuryWatch.com) We will start with the more recent case, Torkie-Tork v. [read post]
13 Feb 2009, 11:10 am
Parents Need To Be Aware Of These Two Serious And Potentially Fatal Skin Reactions Which Are Associated With Certain Medications (Posted by Tom Lamb at DrugInjuryWatch.com) Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are two rare but life-threatening skin reactions. [read post]
4 Oct 2007, 11:13 am
Merck Addresses Cases Of Fosamax-induced Osteonecrosis Of The Jaw, And Three Reports Of ONJ Are Subject Of A Medical Journal Article (Posted by Tom Lamb at DrugInjuryWatch.com) This article is a review of recent reports about the safety of bisphosphonates, with an emphasis on Merck's Fosamax and its association with osteonecrosis of the jaw (ONJ). [read post]
2 May 2011, 1:12 pm
April 2011 Edition Of BMJ Breaks News And Provides Insight From One Who Saw An Increased Risk Of Pancreatitis (Posted by Tom Lamb at DrugInjuryWatch.com) According to a news item published April 11, 2011 by The British Medical Journal (BMJ), letters written by Merck and Novo Nordisk to Anil Rustgi, the editor-in-chief of Gastroenterology, resulted in that journal withdrawing an article which it had posted on its website about how Januvia (sitagliptin)… [read post]
1 Feb 2008, 2:53 pm
Three Medical Journal Articles From Late 2007 Shed More Light On Risk Factors, Prevention, And Treatment Of These Serious Bone Diseases Associated With Fosamax And Similar Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) We start our review of recent medical journal articles about bisphosphonate-induced osteonecrosis and osteomyelitis of the jaw with a November 2007 article, "Bisphosphonates and Bisphosphonate Induced Osteonecrosis", written by Yoh Sawatari and… [read post]
